Professor Crosslin’s academic and professional research experience has been focused on statistical genetics and bioinformatics with applications to complex diseases. Under the direction of Professor Elizabeth Hauser, his doctoral research in Computational Biology and Bioinformatics at Duke University focused on the central theme of modeling metabolic pathways through dimension reduction techniques of genomics data to understand the etiology of complex traits such as cardiovascular disease. Under the direction of Professors Gail Jarvik, Bruce Weir, and Debbie Nickerson, Dr. Crosslin’s postdoctoral training at the University of Washington (UW) focused on the areas of clinical applications of genetics, statistical genetics, and sequencing technologies. This led to an Acting Instructor faculty position in Genome Sciences at UW, and ultimately an Associate Professor position in the Department of Biomedical Informatics and Medical Education (BIME) at UW. In addition to the BIME faculty appointment, Dr. Crosslin received an affiliate faculty appointment at Kaiser Permanente Washington Health Research Institute, Seattle, WA, adjunct faculty appointments in Genome Sciences and the Institute for Public Health Genetics at UW.
In 2021, Professor Crosslin joined the Division of Biomedical Informatics and Genomics in the John W. Deming Department of Medicine, Tulane University School of Medicine, as an Associate Professor, and will serve as the Director of Biomedical Informatics in the Tulane University Biomedical Sciences Graduate Program. Upon his move to Tulane University School of Medicine, Professor Crosslin received affiliate faculty appointments in the Department of Biomedical Informatics and Medical Education, Department of Genome Sciences, and the Institute for Public Health Genetics all at UW. He also received an affiliate faculty appointment at Kaiser Permanente Washington Health Research Institute, Seattle, WA. Finally, Professor Crosslin has served on an advisory board for Optum Labs (formerly UnitedHealth Group Research and Development) to guide the implementation of cohort-level precision medicine efforts since 2018. When not spending time with his daughters, Dr. Crosslin enjoys training, boating, and college football.
